Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Lawandi

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|March 29, 2019
Triazole Antifungal Susceptibility Patterns among <i>Aspergillus</i> Species in Québec, CanadaMatthew P Cheng, Alexander Lawandi, Todd C Lee, et al.
Critical Care Medicine|December 14, 2023
The authors replyAlexander Lawandi, Marissa Oshiro, Sarah Warner, et al.
Jac-Antimicrobial Resistance|May 1, 2023
Association between minimum inhibitory concentration values and mortality risk in patients with <i>Stenotrophomonas maltophilia</i> infections: a retrospective cohort study of electronic health records from 148 US hospitalsSadia H Sarzynski, Alexander Lawandi, Sarah Warner, et al.
Critical Care Medicine|July 3, 2023
Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008-2017Alexander Lawandi, Marissa Oshiro, Sarah Warner, et al.
The Lancet. Infectious Diseases|October 13, 2024
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulationAhmed Babiker, Sarah Warner, Xiaobai Li, et al.
Open Forum Infectious Diseases|January 6, 2022
On the Treatment of <i>Pneumocystis jirovecii</i> Pneumonia: Current Practice Based on Outdated EvidenceEmily G McDonald, Guillaume Butler-Laporte, Olivier Del Corpo, et al.
Egastroenterology|February 13, 2025
Causal role of the gut microbiome in certain human diseases: a narrative reviewConnor Prosty, Khaled Katergi, Jesse Papenburg, et al.
Open Forum Infectious Diseases|November 19, 2020
Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series AnalysisGuillaume Butler-Laporte, Matthew P Cheng, Daniel J G Thirion, et al.
JAMA Network Open|June 27, 2024
Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US HospitalsChanu Rhee, Tom Chen, Sameer S Kadri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2021
Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021Alexander Lawandi, Sarah Warner, Junfeng Sun, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|March 29, 2019
Triazole Antifungal Susceptibility Patterns among <i>Aspergillus</i> Species in Québec, CanadaMatthew P Cheng, Alexander Lawandi, Todd C Lee, et al.
Critical Care Medicine|December 14, 2023
The authors replyAlexander Lawandi, Marissa Oshiro, Sarah Warner, et al.
Jac-Antimicrobial Resistance|May 1, 2023
Association between minimum inhibitory concentration values and mortality risk in patients with <i>Stenotrophomonas maltophilia</i> infections: a retrospective cohort study of electronic health records from 148 US hospitalsSadia H Sarzynski, Alexander Lawandi, Sarah Warner, et al.
Critical Care Medicine|July 3, 2023
Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008-2017Alexander Lawandi, Marissa Oshiro, Sarah Warner, et al.
The Lancet. Infectious Diseases|October 13, 2024
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulationAhmed Babiker, Sarah Warner, Xiaobai Li, et al.
Open Forum Infectious Diseases|January 6, 2022
On the Treatment of <i>Pneumocystis jirovecii</i> Pneumonia: Current Practice Based on Outdated EvidenceEmily G McDonald, Guillaume Butler-Laporte, Olivier Del Corpo, et al.
Egastroenterology|February 13, 2025
Causal role of the gut microbiome in certain human diseases: a narrative reviewConnor Prosty, Khaled Katergi, Jesse Papenburg, et al.
Open Forum Infectious Diseases|November 19, 2020
Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series AnalysisGuillaume Butler-Laporte, Matthew P Cheng, Daniel J G Thirion, et al.
JAMA Network Open|June 27, 2024
Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US HospitalsChanu Rhee, Tom Chen, Sameer S Kadri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2021
Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021Alexander Lawandi, Sarah Warner, Junfeng Sun, et al.
Pageof 5